21 December 2014

Plethora treatment wins NHS approval

15/04/2011 Ben Jaglom

Specialist pharmaceutical concern Plethora Solutions Holdings (PLE) says it has won approval for its vaginal dryness treatment Hyalofemme from the NHS for prescription.

The agreement means that doctors in the UK will now be able to write prescriptions for Hyalofemme for the first time for atrophic vaginitis, commonly referred to as vaginal dryness. Traditional treatments involve the use of hormonal creams containing estrogen, but such creams are often inappropriate for cancer patients, who often suffer vaginal dryness as a side effect of cancer treatment.

Chairman Bill Robinson remarks the decision by the NHS should 'increase the commercial value of our pipeline by exploiting products secured last year'. He adds that the release of Hyalofemme is an 'important treatment' for atrophic vaginitis.

Following the announcement analysts at house broker Daniel Stewart held their forecasts of a year-end loss of £1.3 million (2010: loss of £1.5 million) on revenue up £100,000 to £1.2 million. They have pencilled in a loss per share of 2.5p for 2011 and a further loss of 3.4p a share for 2012.

Shares in Plethora were up 0.25p this morning following the announcement to 7.5p, the price at which Growth Company Investor recommended them earlier this month. A good sign for the company's prospects, Hyalofemme will be prescribed both for those being treated for cancer and women going through the menopause. We therefore reiterate our speculative buy rating.

Tags: AIM market, Menopause, Pharma, Plethora Solutions Holdings, Urology Company, Vaginal dryness

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2014

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1,044 AIM-quoted companies. The full report is available to order for £365 + VAT. Click here for more info

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Brazil's electricity sector is in need of modernisation

Cyan grabs Brazil win 18/12/2014

Smart metering outfit Cyan Holdings (AIM:CYAN) has won an order for 1,000 modules in Brazil.

Ideagen raises £17.5m and nabs Gael 18/12/2014

NHS Software specialist Ideagen (AIM:IDEA) is to acquire fellow software play Gael for £18 million.

Range obtains $110m of cash while board quits 12/12/2014

Oil explorer Range Resources (AIM:RRL) has announced a package of funding worth $110 million to continue its exploration efforts while reporting a raft of resignations.

Tags: Oil and gas

Porta grabs Publicasity 11/12/2014

PR group Porta Communications (AIM:PTCM) has acquired food and drink PR concern Publicasity.

Tags: British Media

Rare Earth excited by Yangibana 03/12/2014

Rare Earth Minerals (AIM:REM) reported an update on the hunt for the minerals in Western Australia.

Tags: Mining

Universe expands to Morrisons 03/12/2014

Loyalty card and petrol forecourt technology specialist Universe Group (AIM:UNG) reported on a deal with supermarket chain Morrisons.

 

Tags: Retail, Technology

More News